Related Experiment Video

Updated: Sep 26, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.3K

Novel treatments in B cell non-Hodgkin's lymphomas

Yazeed Sawalha1, Kami Maddocks1

  • 1Internal Medicine - Division of Hematology, Ohio State University Comprehensive Cancer Centre, Columbus, OH, USA.

BMJ (Clinical Research Ed.)
|April 21, 2022
PubMed

Insights

Novel small molecule inhibitors and immunotherapies offer new hope for B cell non-Hodgkin's lymphomas. This review covers approved and emerging treatments, focusing on their mechanisms, efficacy, and future potential.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Advances in lymphoma biology and cancer immunology have driven therapeutic innovation.
  • B cell non-Hodgkin's lymphomas (NHL) represent a significant area of clinical need.

Purpose of the Study:

  • To review recently US Food and Drug Administration-approved novel treatments for B cell NHL.
  • To discuss the mechanisms of action, efficacy, safety, and clinical roles of these new therapies.
  • To explore emerging treatments with unique mechanisms and promising early clinical data.

Main Methods:

  • Literature review of recent clinical practice guidelines and regulatory approvals.
  • Analysis of scientific publications detailing novel small molecule inhibitors and immunotherapies.
  • Synthesis of data on treatment efficacy, safety profiles, and therapeutic positioning.

Main Results:

  • Several novel small molecule inhibitors and immunotherapies are now standard care for B cell NHL.
  • These treatments demonstrate significant efficacy and manageable safety profiles across various B cell NHL subtypes.
  • Emerging therapies show encouraging results, suggesting future treatment advancements.

Conclusions:

  • The therapeutic landscape for B cell NHL has been transformed by new targeted therapies and immunotherapies.
  • Understanding the mechanisms, efficacy, and safety of these agents is crucial for optimal patient care.
  • Ongoing research into novel treatments promises further improvements in outcomes for B cell NHL patients.

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

51
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
689
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
523
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
533
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K